1 / 10

Aarkstore - Ulcerative Colitis - Pipeline Review, H2 2014

This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ http://goo.gl/mgiA4M

kaveriRai9023
Télécharger la présentation

Aarkstore - Ulcerative Colitis - Pipeline Review, H2 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmaceutical and Healthcare Market Research Report Ulcerative Colitis - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

  2. Summary Ulcerative Colitis - Pipeline Review, H2 2014, provides an overview of the Ulcerative Colitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ulcerative Colitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. For More Information Visit : www.aarkstore.com

  3. Scope The report provides a snapshot of the global therapeutic landscape of Ulcerative ColitisThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Ulcerative Colitis and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Ulcerative Colitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages Browse full report or Sample Request @ http://www.aarkstore.com/pharmaceuticals-healthcare/60599/type-2-diabetes-pipeline-review-h2-2014 For More Information Visit : www.aarkstore.com

  4. Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Ulcerative ColitisPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Ulcerative Colitis pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and ScopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

  5. Table of Content IntroductionGlobal Markets Direct Report CoverageUlcerative Colitis OverviewTherapeutics DevelopmentPipeline Products for Ulcerative Colitis - OverviewPipeline Products for Ulcerative Colitis - Comparative AnalysisUlcerative Colitis - Therapeutics under Development by CompaniesUlcerative Colitis - Therapeutics under Investigation by Universities/InstitutesUlcerative Colitis - Pipeline Products GlanceLate Stage ProductsClinical Stage ProductsEarly Stage ProductsUnknown Stage ProductsUlcerative Colitis - Products under Development by CompaniesUlcerative Colitis - Products under Investigation by Universities/InstitutesUlcerative Colitis - Companies Involved in Therapeutics DevelopmentAjinomoto Pharmaceuticals Co., Ltd. For More Information Visit : www.aarkstore.com

  6. List of Tables Number of Products under Development for Ulcerative Colitis, H2 2014Number of Products under Development for Ulcerative Colitis - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Number of Products under Development by Companies, H2 2014 (Contd..1)Number of Products under Development by Companies, H2 2014 (Contd..2)Number of Products under Development by Companies, H2 2014 (Contd..3)Number of Products under Development by Companies, H2 2014 (Contd..4)Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Late Stage Development, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Comparative Analysis by Early Stage Development, H2 2014Comparative Analysis by Unknown Stage Development, H2 2014Products under Development by Companies, H2 2014Products under Development by Companies, H2 2014 (Contd..1)Products under Development by Companies, H2 2014 (Contd..2)Products under Development by Companies, H2 2014 (Contd..3) For More Information Visit : www.aarkstore.com

  7. List of Figures Number of Products under Development for Ulcerative Colitis, H2 2014Number of Products under Development for Ulcerative Colitis - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Number of Products under Investigation by Universities/Institutes, H2 2014Comparative Analysis by Late Stage Development, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Comparative Analysis by Early Stage Products, H2 2014Comparative Analysis by Unknown Stage Development, H2 2014Assessment by Monotherapy Products, H2 2014Assessment by Combination Products, H2 2014Number of Products by Top 10 Targets, H2 2014Number of Products by Stage and Top 10 Targets, H2 2014Number of Products by Top 10 Mechanism of Actions, H2 2014 For More Information Visit : www.aarkstore.com

  8. Related Reports Sinusitis-Pipeline Insights, 2015 Oligodendroglioma-Pipeline Insights, 2015 Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2015 Fatty Liver Disease-Pipeline Insights, 2015 Skin And Skin Structure Infections by S.Pneumoniae-Pipeline Insights, 2015 Opioid-Induced Constipation (OIC)-Pipeline Insights, 2015 Female Infertility-Pipeline Insights, 2015 Optic Neuritis-Pipeline Insights, 2015 For More Information Visit : www.aarkstore.com

  9. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  10. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related